JFLB(002762)2025-01-21 09:30Financial Performance Expectations - The company expects a net profit attributable to shareholders of between 60 million and 90 million CNY, representing a growth of 355.38% to 483.06% compared to a loss of 23.49 million CNY in the same period last year[3]. - The company anticipates a net loss of between 28 million and 42 million CNY after deducting non-recurring gains and losses, which is a decrease of 8.95% to 63.42% compared to a loss of 25.70 million CNY in the previous year[3]. - The expected operating revenue for 2024 is between 245 million and 260 million CNY, an increase from 204.17 million CNY in the previous year[3]. - The company warns that the expected operating revenue for 2024 is below 300 million CNY, and the net profit after deducting non-recurring gains and losses is negative, which may lead to a *ST warning after the annual report disclosure[7]. - The financial data for the 2024 performance forecast is preliminary and unaudited, with specific figures to be detailed in the annual report[8]. Acquisitions and Revenue Contributions - The company acquired 51% stakes in Zhuhai Hanfei Medical Beauty Clinic and Zhongshan Hanfei Medical Beauty Clinic in December 2024, contributing approximately 6 million CNY to the revenue for that month[5]. - The company also acquired 53% of Yaomei (Guangdong) Technology Development Co., which generated approximately 51 million CNY in revenue from June to December 2024[6]. Performance Compensation and Investment Losses - The company expects to recognize approximately 120 million CNY in performance compensation income due to the anticipated failure of the performance commitments by the investment party of Guangdong Hanfei Hospital Investment Co.[6]. - The company projects an investment loss and long-term equity investment impairment of approximately 28 million CNY due to expected losses from Hanfei Investment's operations[6].